GPT Healthcare Q1 FY27 Share Price & Earnings Call Analysis
- Market cap
- ₹1,089 Cr
- P/E
- 23.04
- ROE
- 16.66%
- PEG
- 6.25
- Price to sales
- 2.21
- Debt to equity
- 0.34
- 52W high / low
- ₹170 / ₹115
- Sales growth (5Y)
- 14.25%
- EBITDA margin
- 18.51%
- Net profit margin
- 9.12%
- Promoter holding
- 65.57%
- Sales (last year)
- ₹492 Cr
Incorporated in 1989, GPT Healthcare Ltd is engaged in running hospitals and providing medical services[1]
Guidance scorecard · Q1 FY27 call
What GPT Healthcare Ltd's management guided
and where it ranks in Healthcare Services
Healthcare Services
RevenueQ1 FY27 call
10–20%- GPT Healthcare expects continued revenue growth driven by higher occupancy and improved specialty mix across hospitals.
- Mature hospitals show steady patient inflows with network occupancy at 45.5%, and 58.07% in mature hospitals excluding Raipur.
- Expansion projects like the 155-bed Jamshedpur hospital commissioning in Q4 FY27 and plans for a seventh hospital will increase capacity beyond 1,000 beds in 2 years.
- Specialty services, including liver transplants (around 10 per year initially at Raipur), oncology ramp-up, and robotic surgeries, are expected to drive higher ARPOB and patient volumes.
- Newer hospitals like Raipur and Dumdum are ramping up occupancy and revenue, with Dumdum targeting optimum occupancy by Q3 FY27.
2 more points from GPT Healthcare Ltd's call on revenue
Create a free account to keep reading this call
MarginsQ1 FY27 call
Up 2%+See what GPT Healthcare Ltd said on margins — free account, 30 seconds.
CapexQ1 FY27 call
Planned- GPT Healthcare is progressing on the construction of a 155-bed tertiary care hospital in Jamshedpur, expected to be commissioned in Q4 FY27.
- The company is evaluating opportunities for a seventh hospital, aiming to increase network capacity to over 1,000 beds in the next 2 years.
- Expansion plans include both acquisition and greenfield projects in Tier 1 and Tier 2 cities like Cuttack, Ranchi, Patna, Banaras, and Prayagraj.
- New hospitals such as Raipur and Jamshedpur are developed on an asset-light model, leasing customized buildings to reduce real estate investments.
2 more points from GPT Healthcare Ltd's call on capex
Create a free account to keep reading this call
FundraisingQ1 FY27 call
PlannedSee what GPT Healthcare Ltd said on fundraising — free account, 30 seconds.
Order bookQ1 FY27 call
- The company is progressing with the construction of a 155-bed tertiary care hospital at Jamshedpur, expected to be commissioned in Q4 FY27.
- Evaluation of opportunities for a seventh hospital is ongoing, targeting Tier 1 and Tier 2 cities like Cuttack, Ranchi, Patna, Banaras, and Prayagraj.
- Both greenfield and acquisition opportunities are being considered, with no definitive order or project confirmed yet.
- Asset-light models are being used for new hospitals like Raipur and Jamshedpur to reduce capital investment.
Ranges are what management guided for revenue growth and margins on the latest earnings call. Not investment advice, and not a forecast of returns.
Potential multibaggers · Q2 FY27
Potential multibaggers in Healthcare Services
on management's own guidance
- Strong growth2
- Strong growth1
- Aster DM Quality Care LtdGood growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Peers
Healthcare Services companies ranked on guidance
| # | Company | Revenue guided | Margin guided | Market cap | P/E |
|---|---|---|---|---|---|
| 1 | 40%+ | Up 2%+ | ₹903 Cr | — | |
| 2 | 40%+ | Flat | ₹583 Cr | 22.2 | |
| 3 | Aster DM Quality Care Ltd | 20–40% | Up 2%+ | ₹58,782 Cr | 162.9 |
| 4 | 20–40% | Up 0–2% | ₹1,730 Cr | 17.5 | |
| 5 | 20–40% | Up 0–2% | ₹580 Cr | 11.9 | |
| 6 | 20–40% | Flat | ₹1.13L Cr | 53.9 |
Sign up free to see every company in the sector ranking and track GPT Healthcare Ltd.
Pro shows every company guiding 40%+ revenue growth →Full Healthcare Services rankingFinancials of GPT Healthcare Ltd
Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.
Financials of GPT Healthcare Ltd
Quarterly Results
Quarter-by-quarter operating performance
| Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 96 | 96 | 108 | 97 | 99 | 98 | 106 | 102 | 101 | 107 | 119 | 120 | 126 |
| Expenses + | 72 | 77 | 83 | 76 | 76 | 80 | 82 | 81 | 81 | 90 | 96 | 99 | 103 |
| Operating Profit | 24 | 19 | 25 | 21 | 23 | 18 | 23 | 21 | 21 | 17 | 23 | 21 | 23 |
| OPM % | 25% | 20% | 23% | 22% | 23% | 18% | 22% | 21% | 20% | 16% | 19% | 17% | 18% |
| Other Income + | 2 | 1 | 1 | 1 | 2 | 2 | 3 | 2 | 2 | 2 | 1 | 1 | 2 |
| Interest | 3 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 |
| Depreciation | 4 | 4 | 4 | 4 | 5 | 5 | 5 | 5 | 5 | 6 | 7 | 7 | 7 |
| Profit before tax | 19 | 14 | 19 | 16 | 18 | 15 | 21 | 18 | 16 | 11 | 15 | 13 | 16 |
| Tax % | 46% | 30% | 31% | 28% | 30% | 32% | 28% | 30% | 21% | 31% | 30% | 27% | 8% |
| Net Profit + | 10 | 10 | 14 | 11 | 13 | 10 | 15 | 12 | 13 | 8 | 11 | 9 | 15 |
| EPS in Rs | 1.30 | 1.25 | 1.69 | 1.44 | 1.56 | 1.21 | 1.81 | 1.49 | 1.57 | 0.94 | 1.29 | 1.14 | 1.78 |
Financials of GPT Healthcare Ltd
Profit & Loss
Annual income statement trend
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Sales + | 212 | 243 | 337 | 361 | 400 | 407 | 473 |
| Expenses + | 176 | 194 | 263 | 287 | 312 | 324 | 388 |
| Operating Profit | 36 | 49 | 74 | 74 | 88 | 83 | 84 |
| OPM % | 17% | 20% | 22% | 21% | 22% | 20% | 18% |
| Other Income + | 4 | 6 | 5 | 6 | 5 | 8 | 6 |
| Interest | 14 | 14 | 11 | 9 | 7 | 3 | 8 |
| Depreciation | 11 | 12 | 14 | 15 | 18 | 19 | 27 |
| Profit before tax | 15 | 29 | 54 | 56 | 68 | 69 | 55 |
| Tax % | 26% | 27% | 23% | 30% | 30% | 28% | 23% |
| Net Profit + | 11 | 21 | 42 | 39 | 48 | 50 | 42 |
| EPS in Rs | 6.11 | 11.76 | 5.21 | 4.88 | 5.82 | 6.08 | 5.15 |
| Dividend Payout % | 0% | 47% | 0% | 102% | 60% | 41% | 49% |
Financials of GPT Healthcare Ltd
Balance Sheet
Capital structure and asset base
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Equity Capital | 18 | 18 | 80 | 80 | 82 | 82 | 82 |
| Reserves | 109 | 116 | 78 | 85 | 136 | 166 | 187 |
| Borrowings + | 157 | 166 | 102 | 82 | 31 | 35 | 91 |
| Other Liabilities + | 25 | 18 | 63 | 79 | 96 | 101 | 104 |
| Total Liabilities | 308 | 317 | 323 | 327 | 346 | 384 | 465 |
| Fixed Assets + | 226 | 220 | 220 | 228 | 224 | 228 | 342 |
| CWIP | 2 | 0 | 1 | 3 | 6 | 46 | 1 |
| Investments | 1 | 1 | 10 | 13 | 30 | 32 | 43 |
| Other Assets + | 80 | 97 | 92 | 83 | 85 | 78 | 79 |
| Total Assets | 308 | 317 | 323 | 327 | 346 | 384 | 465 |
Financials of GPT Healthcare Ltd
Cash Flows
Operating, investing and financing cash movement
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Cash from Operating Activity + | 41 | 43 | 66 | 66 | 69 | 67 | 81 |
| Cash from Investing Activity + | -54 | -16 | -5 | 5 | -25 | -33 | -47 |
| Cash from Financing Activity + | 12 | -22 | -57 | -73 | -48 | -35 | -31 |
| Net Cash Flow | -1 | 4 | 3 | -2 | -5 | -0 | 2 |
| Free Cash Flow | -5 | 38 | 59 | 58 | 50 | 18 | 40 |
| CFO/OP | 116% | 88% | 107% | 103% | 95% | 101% | 112% |
Financials of GPT Healthcare Ltd
Ratios
Working capital efficiency and return ratios
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Debtor Days | 30 | 26 | 15 | 21 | 22 | 18 | 16 |
| Inventory Days | 60 | 41 | 30 | 43 | 36 | 41 | 43 |
| Days Payable | 314 | 165 | 121 | 161 | 165 | 161 | 170 |
| Cash Conversion Cycle | -224 | -98 | -76 | -97 | -106 | -102 | -112 |
| Working Capital Days | -4 | 32 | 3 | -18 | -16 | -28 | 4 |
| ROCE % | 14% | 23% | 25% | 30% | 27% | 20% |
Guidance history
How GPT Healthcare Ltd's guidance has moved, call by call
| Call | Revenue | Margins | Capex | Fundraising | Order book |
|---|---|---|---|---|---|
| Q1 FY27 call → | 10–20% | Up 2%+ | Planned | Planned | — |
| Q4 FY26 call → | 10–20% | Flat | Planned | — | — |
| Q3 FY26 call → | 10–20% | Flat | Planned | — | — |
| Q2 FY26 call → | 10–20% | Up 2%+ | Planned | — | — |
What management guided on each call, newest first. Not investment advice, and not a forecast of returns.
Momentum score · price trend
21 out of 100 — Cooling
Over the past year its share price has done worse than most of the stocks we track.
| Period | Share price change | Better than … of 1,910 stocks |
|---|---|---|
| Last 12 months | −11.4% | 49% |
| Last 6 months | −4.2% | 49% |
| Last 3 months | −22.2% | 16% |
The price is 30.8% below its all-time high of ₹191.8 (2 Mar 2024). Stocks more than 20% below their peak have their score halved, so 42 became 21.
How we calculate it
“Better than 30%” means that over that period the share price did better than 30 out of every 100 stocks we track (1,910 Indian companies worth ₹500 Cr or more, with at least a year of prices).
The score weighs the longer periods more: 40% × 12-month + 40% × 6-month + 20% × 3-month. For GPT Healthcare Ltd: 0.4 × 49 + 0.4 × 49 + 0.2 × 16 = 42, halved to 21 because the price is more than 20% below its all-time high.
Strengthening is 70 and above, Steady 40 to 70, Cooling below 40. Scores are recalculated every night after the market closes.
Full methodology →This describes only how the share price has moved up to 30 Oct 2026, compared with other stocks. It says nothing about the business, and it is not a prediction, a price target or a recommendation to buy or sell.
Continue your research
What GPT Healthcare Ltd's management said in earlier quarters
Others in Healthcare Services this season
- Rainbow Childrens Medicare Ltd (Q2 FY27)
Year-on-year (YoY) growth in revenue: 23.2% . Key investor presentation takeaways from Rainbow Childrens Medicare Ltd's Q2 FY27 investor presentation — and how
- Narayana Hrudayalaya Ltd (Q2 FY27)
Consolidated operating revenue for Q2 FY27: ₹28,440 Mn, up 73.0% YoY (Page 15, 16). Key investor presentation takeaways from Narayana Hrudayalaya Ltd's Q2 FY27
- Artemis Medicare Services Ltd (Q2 FY27)
Q2 FY27 consolidated revenue from operations: INR 31,104 Lacs, up 13.2% YoY (Page 39, 40, 20). Key investor presentation takeaways from Artemis Medicare Service
- Max Healthcare Institute Ltd (Q2 FY27)
Q2 FY27 Gross Revenue: ₹3,219 Cr, up 20% YoY (Page 4, 17) . Key investor presentation takeaways from Max Healthcare Institute Ltd's Q2 FY27 investor presentatio